Gemcitabine
NDC 25021-239, gemcitabine, injection, solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-239
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209077
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GEMCITABINE HYDROCHLORIDE38 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-239-05 | 25021023905 | 1 VIAL in 1 CARTON (25021-239-05) / 5.26 mL in 1 VIAL |
| 25021-239-26 | 25021023926 | 1 VIAL in 1 CARTON (25021-239-26) / 26.3 mL in 1 VIAL |
| 25021-239-52 | 25021023952 | 1 VIAL in 1 CARTON (25021-239-52) / 52.6 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/22af3507-4b4f-4cad-9d61-89ffc4aabbc7Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-239
Use it
Look up 25021-239 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-239. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.